Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

This study has been terminated.

(Parent protocol (SWOG S0816 / AMC-073) discontinued)

Sponsor:

Collaborators:

The EMMES Corporation

Information provided by (Responsible Party):

AIDS Malignancy Clinical Trials Consortium

ClinicalTrials.gov Identifier:

NCT01319526

First received: December 18, 2010

Last updated: August 27, 2014

Last verified: August 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2013
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)